Using microwave thermal ablation to develop a subtotal, cortical-sparing approach to the management of primary aldosteronism

References

• Monticone S, Burrello J, Tizzani D, et al. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice. J Am Coll Cardiol. 2017;69:1811–1820.
   PubMed Web of Science ®Google Scholar
• Hundemer GL, Curhan GC, Yozamp N, et al. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study. Lancet Diabetes Endocrinol. 2018;6:51–59.
   PubMed Web of Science ®Google Scholar
• Hundemer GL, Curhan GC, Yozamp N, et al. Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism. JAMA Cardiol. 2018;3:768–774.
   PubMed Web of Science ®Google Scholar
• Hundemer GL, Curhan GC, Yozamp N, et al. Renal outcomes in medically and surgically treated primary aldosteronism. Hypertension. 2018;72:658.
   PubMed Web of Science ®Google Scholar
• Reincke M, Beuschlein F, Bidlingmaier M, et al. Progress in primary aldosteronism. Horm Metab Res. 2010;42:371–373.
   PubMed Web of Science ®Google Scholar
• Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889–1916.
   PubMed Web of Science ®Google Scholar
• Mulatero P, Monticone S, Burrello J, et al. Guidelines for primary aldosteronism: uptake by primary care physicians in Europe. J Hypertens. 2016;34:2253–2257.
   PubMed Web of Science ®Google Scholar
• Boulkroun S, Golib Dzib JF, Samson-Couterie B, et al. KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling. Mol Cell Endocrinol. 2013;371:221–227.
   PubMed Web of Science ®Google Scholar
• Omata K, Anand SK, Hovelson DH, et al. Aldosterone-producing cell clusters frequently harbor somatic mutations and accumulate with age in normal adrenals. J Endocr Soc. 2017;1:787–799.
   PubMed Web of Science ®Google Scholar
• Williams TA, Lenders JWM, Mulatero P, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol. 2017;5:689–699.
   PubMed Web of Science ®Google Scholar
• Balla A, Ortenzi M, Palmieri L, et al. Laparoscopic bilateral anterior transperitoneal adrenalectomy: 24 years experience. Surg Endosc. 2019;33:1–351.
   Web of Science ®Google Scholar
• Hasegawa T, Yamakado K, Nakatsuka A, et al. Unresectable adrenal metastases: clinical outcomes of radiofrequency ablation. Radiology. 2015;277:584–593.
   PubMed Web of Science ®Google Scholar
• Sarwar A, Brook OR, Vaidya A, et al. Clinical outcomes following percutaneous radiofrequency ablation of unilateral aldosterone-producing adenoma: comparison with adrenalectomy. J Vasc Interv Radiol. 2016;27:961–967.
   PubMed Web of Science ®Google Scholar
• Yang MH, Tyan YS, Huang YH, et al. Comparison of radiofrequency ablation versus laparoscopic adrenalectomy for benign aldosterone-producing adenoma. Radiol Med. 2016;121:811–819.
   PubMed Web of Science ®Google Scholar
• Fallahi H, Clausing D, Shahzad A, et al. Microwave antennas for thermal ablation of benign adrenal adenomas. Biomed Phys Eng Express. 2019;5:025044.
   Web of Science ®Google Scholar
• Sebek J, Curto S, Bortel R, et al. Analysis of minimally invasive directional antennas for microwave tissue ablation. Int J Hyperthermia. 2017;33:51–60.
   PubMed Web of Science ®Google Scholar
• Gomez-Sanchez CE, Qi X, Velarde-Miranda C, et al. Development of monoclonal antibodies against human CYP11B1 and CYP11B2. Mol Cell Endocrinol. 2014;383:111–117.
   PubMed Web of Science ®Google Scholar
• Meyer LS, Wang X, Susnik E, et al. Immunohistopathology and steroid profiles associated with biochemical outcomes after adrenalectomy for unilateral primary aldosteronism. Hypertension. 2018;72:650.
   PubMed Web of Science ®Google Scholar
• Blake MJ, Udelsman R, Feulner GJ, et al. Stress-induced heat shock protein 70 expression in adrenal cortex: an adrenocorticotropic hormone-sensitive, age-dependent response. Proc Natl Acad Sci USA. 1991;88:9873–9877.
   PubMed Web of Science ®Google Scholar
• Udelsman R, Blake MJ, Stagg CA, et al. Endocrine control of stress-induced heat shock protein 70 expression in vivo. Surgery. 1994;115:611–616.
   PubMed Web of Science ®Google Scholar
• Sims GP, Rowe DC, Rietdijk ST, et al. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol. 2010;28:367–388.
   PubMed Web of Science ®Google Scholar
• Singh Ospina N, Thompson GB, Lee RA, et al. Safety and efficacy of percutaneous parathyroid ethanol ablation in patients with recurrent primary hyperparathyroidism and multiple endocrine neoplasia type 1. J Clin Endocrinol Metab. 2015;100:E87–90.
   PubMed Web of Science ®Google Scholar
• Morhard R, Nief C, Barrero Castedo C, et al. Development of enhanced ethanol ablation as an alternative to surgery in treatment of superficial solid tumors. Sci Rep. 2017;7:8750.
   PubMed Web of Science ®Google Scholar
• Liu SY, Ng EK, Lee PS, et al. Radiofrequency ablation for benign aldosterone-producing adenoma: a scarless technique to an old disease. Ann Surg. 2010;252:1058–1064.
   PubMed Web of Science ®Google Scholar
• Liu SY, Chu CC, Tsui TK, et al. Aldosterone-producing adenoma in primary aldosteronism: CT-guided radiofrequency ablation-long-term results and recurrence rate. Radiology. 2016;281:625–634.
   PubMed Web of Science ®Google Scholar
• Liu SY, Chu CM, Kong AP, et al. Radiofrequency ablation compared with laparoscopic adrenalectomy for aldosterone-producing adenoma. Br J Surg. 2016;103:1476–1486.
   PubMed Web of Science ®Google Scholar
• Sebek J, Albin N, Bortel R, et al. Sensitivity of microwave ablation models to tissue biophysical properties: a first step toward probabilistic modeling and treatment planning. Med Phys. 2016;43:2649
   PubMed Web of Science ®Google Scholar
• Monticone S, Satoh F, Dietz AS, et al. Clinical management and outcomes of adrenal hemorrhage following adrenal vein sampling in primary aldosteronism. Hypertension. 2016;67:146–152.
   PubMed Web of Science ®Google Scholar
• Espinosa De Ycaza AE, Welch TL, Ospina NS, et al. Image-guided thermal ablation of adrenal metastases: hemodynamic and endocrine outcomes. Endocr Pract. 2017;23:132–140.
   PubMed Web of Science ®Google Scholar
• Burton TJ, Mackenzie IS, Balan K, et al. Evaluation of the sensitivity and specificity of (11)C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn's adenomas. J Clin Endocrinol Metab. 2012;97:100–109.
   PubMed Web of Science ®Google Scholar
• Ouyang J, Hardy R, Brown M, et al. (11)C-metomidate PET-CT scanning can identify aldosterone-producing adenomas after unsuccessful lateralisation with CT/MRI and adrenal venous sampling. J Hum Hypertens. 2017;31:483–484.
   PubMed Web of Science ®Google Scholar
• O'Shea PM, O'Donoghue D, Bashari W, et al. (11) C-Metomidate PET/CT is a useful adjunct for lateralization of primary aldosteronism in routine clinical practice. Clin Endocrinol. 2019;90:670–679.
   PubMed Web of Science ®Google Scholar
• Gioco F, Seccia TM, Gomez-Sanchez EP, et al. Adrenal histopathology in primary aldosteronism: Is it time for a change? Hypertension. 2015;66:724–730.
   PubMed Web of Science ®Google Scholar